Heidi M Mansour

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Walled Carbon Nanotubes

Top Venues

International journal of molecular sciences

Therapeutic advances in respiratory disease

This page only lists publications with an associated author ORCID identifier.

Publications

David Encinas-Basurto, Maria F Acosta, Basanth Babu Eedara, Jeffrey R Fineman, Stephen M Black, Heidi M Mansour
Design and comprehensive characterization of dry powder inhalation aerosols of simvastatin DPPC/DPPG lung surfactant-mimic nanoparticles/microparticles for pulmonary nanomedicine. RSC advances 14 (40) (2024)
Basanth Babu Eedara, Bhagyashree Manivannan, Wafaa Alabsi, Bo Sun, Clara Curiel-Lewandrowski, Tianshun Zhang, Ann M Bode, Heidi M Mansour
Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032. International journal of molecular sciences 24 (21) (2023)
Victor H Ruiz, David Encinas-Basurto, Bo Sun, Basanth Babu Eedara, Eunmiri Roh, Neftali Ortega Alarcon, Clara Curiel-Lewandrowski, Ann M Bode, Heidi M Mansour
Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation. International journal of molecular sciences 24 (10) (2023)
Wafaa Alabsi, Basanth Babu Eedara, David Encinas-Basurto, Robin Polt, Heidi M Mansour
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols. Pharmaceutics 14 (9) (2022)
Neftali Ortega Alarcon, Maddy Jaramillo, Heidi M Mansour, Bo Sun
Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms. Pharmaceutics 14 (7) (2022)
Victor H Ruiz, David Encinas-Basurto, Bo Sun, Basanth Babu Eedara, Sally E Dickinson, Georg T Wondrak, H -H Sherry Chow, Clara Curiel-Lewandrowski, Heidi M Mansour
Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery. Pharmaceutics 14 (4) (2022)
Ernest L Vallorz, David Encinas-Basurto, Rick G Schnellmann, Heidi M Mansour
Design, Development, Physicochemical Characterization, and In Vitro Drug Release of Formoterol PEGylated PLGA Polymeric Nanoparticles. Pharmaceutics 14 (3) (2022)
David Encinas-Basurto, John P Konhilas, Robin Polt, Meredith Hay, Heidi M Mansour
Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release. Pharmaceutics 14 (3) (2022)
Katie L Collins, Usir S Younis, Sasipa Tanyaratsrisakul, Robin Polt, Meredith Hay, Heidi M Mansour, Julie G Ledford
Angiotensin-(1-7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice. Pharmaceutics 13 (10) (2021)
Maria F Acosta, Priya Muralidharan, Carissa L Grijalva, Michael D Abrahamson, Don Hayes, Jeffrey R Fineman, Stephen M Black, Heidi M Mansour
Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy. Therapeutic advances in respiratory disease 15 (2021)
Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, Robin Polt, Julie G Ledford, Heidi M Mansour
Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection. Pharmaceutics 13 (7) (2021)
Don Hayes, Leanna K Darland, Michelle A Hjelm, Heidi M Mansour, Kathryn A Wikenheiser-Brokamp
To treat or not to treat: CFTR modulators after lung transplantation. Pediatric transplantation 25 (4) (2021)
Wafaa Alabsi, Maria F Acosta, Fahad A Al-Obeidi, Meredith Hay, Robin Polt, Heidi M Mansour
Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1-7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers. Pharmaceutics 13 (8) (2021)
Priya Muralidharan, Don Hayes, Jeffrey R Fineman, Stephen M Black, Heidi M Mansour
Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery. Pharmaceutics 13 (12) (2021)